Clinical Outsourcing World Europe addresses the major strategic and operational issues involved in outsourcing. The question now is not whether to outsource but which part of the development programme should be outsourced and how do you outsource efficiently?
World Generic Medicines Congress Europe 2009 addresses the health economics, pricing and competition pressures facing the generics sector in Europe and building scale and value through globalisation.
World Drug Safety Congress Americas addresses the challenges for drug safety professionals Worldwide. The conference addresses the crucial issues in the development and execution of drug safety programmes. Network with drug safety and pharmacovigilance experts, revolutionize your safety strategy.
Health Network Communications in association with the London School of Economics will be running the 3rd annual Pharma Pricing & Market Access Outlook. This is the World’s largest pricing, reimbursement and market access event for the pharmaceutical and biotech community.
Europe’s largest and most highly regarded early development congress will address the critical issues in achieving seamless first in man studies and will provide advice on conducting effective studies that allow you to make the right decision early on in clinical development
The 3rd annual World Drug Safety Congress in Europe addresses the key challenges for drug safety professionals Worldwide. The World Drug Safety Congress addresses the crucial issues in the development and execution of drug safety programmes.
DigiPharm Europe 2009 is one of the largest gatherings of pharmaceutical marketing and communications professionals in Europe. Benchmark strategies to enhance online communication, customer relations, brand awareness and profitability in digital marketing.
The 2nd annual Exploratory Clinical Development World Americas follows the huge success of the inaugural conference in September 2008, to which Health Network attracted a record number of early development scientists and decision makers to explore the challenges of Phase I trials.
World Generic Medicines Congress Americas 2009 addresses the health economics, pricing and competition pressures facing the generics sector in US and building scale and value through globalization.
